Kindred Biosciences, Inc

NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)This U.S. industry comprises establishments primarily engaged in conducting biotechnology (except nanobiotechnology) research and experimental development. Biotechnology (except nanobiotechnology) research and experimental development involves the study of the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. This research and development in biotechnology (except nanobiotechnology) may result in development of new biotechnology (except nanobiotechnology) processes or in prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. Learn more at the U.S. Census Bureau
Name | Role | Address |
---|---|---|
CORPORATION SERVICE COMPANY | Agent | 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA |
Name | Role | Address |
---|---|---|
JOYCE LEE | PRESIDENT | 1555 BAYSHORE HIGHWAY, #200 BURLINGAME, CA 94010 USA |
Name | Role | Address |
---|---|---|
JINEE MAJORS | SECRETARY | 1555 BAYSHORE HIGHWAY, #200 BURLINGAME, CA 94010 USA |
Name | Role | Address |
---|---|---|
DAVID PUGH | TREASURER/VICE PRESIDENT | 1555 BAYSHORE HIGHWAY, #200 BURLINGAME, CA 94010 USA |
Name | Role | Address |
---|---|---|
JOYCE LEE | DIRECTOR | 1555 BAYSHORE HIGHWAY, #200 BURLINGAME, CA 94010 USA |
Number | Name | File Date |
---|---|---|
202332216360 | Application for Certificate of Withdrawal | 2023-04-03 |
202222608970 | Statement of Change of Registered/Resident Agent | 2022-09-01 |
202215305400 | Annual Report | 2022-04-20 |
202192685250 | Annual Report | 2021-02-24 |
202031787530 | Application for Certificate of Authority | 2020-01-10 |
This company hasn't received any reviews.
Date of last update: 03 Jun 2025
Sources: Rhode Island Department of State